GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Price-to-Tangible-Book

Eusol Biotech Co (ROCO:6652) Price-to-Tangible-Book : 2.91 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Price-to-Tangible-Book?

As of today (2024-06-05), Eusol Biotech Co's share price is NT$8.89. Eusol Biotech Co's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was NT$3.05. Hence, Eusol Biotech Co's Price to Tangible Book Ratio of today is 2.91.

The historical rank and industry rank for Eusol Biotech Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6652' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.67   Med: 7.2   Max: 17.03
Current: 3.03

During the past 9 years, Eusol Biotech Co's highest Price to Tangible Book Ratio was 17.03. The lowest was 2.67. And the median was 7.20.

ROCO:6652's Price-to-Tangible-Book is ranked worse than
54.79% of 1221 companies
in the Biotechnology industry
Industry Median: 2.81 vs ROCO:6652: 3.03

A closely related ratio is called PB Ratio. As of today, Eusol Biotech Co's share price is NT$8.89. Eusol Biotech Co's Book Value per Sharefor the quarter that ended in Jun. 2023 was NT$3.06. Hence, Eusol Biotech Co's P/B Ratio of today is 2.91.


Eusol Biotech Co Price-to-Tangible-Book Historical Data

The historical data trend for Eusol Biotech Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co Price-to-Tangible-Book Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 8.96 17.03 5.44 2.67 3.39

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.44 3.18 2.67 4.13 3.39

Competitive Comparison of Eusol Biotech Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Eusol Biotech Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's Price-to-Tangible-Book falls into.



Eusol Biotech Co Price-to-Tangible-Book Calculation

Eusol Biotech Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=8.89/3.054
=2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Eusol Biotech Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co (ROCO:6652) Business Description

Traded in Other Exchanges
N/A
Address
Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co (ROCO:6652) Headlines

No Headlines